G protein-dependent basal and evoked endothelial cell vWF secretion.
Ontology highlight
ABSTRACT: von Willebrand factor (vWF) secretion by endothelial cells (ECs) is essential for hemostasis and thrombosis; however, the molecular mechanisms are poorly understood. Interestingly, we observed increased bleeding in EC-G?13(-/-);G?12(-/-) mice that could be normalized by infusion of human vWF. Blood from G?12(-/-) mice exhibited significantly reduced vWF levels but normal vWF multimers and impaired laser-induced thrombus formation, indicating that G?12 plays a prominent role in EC vWF secretion required for hemostasis and thrombosis. In isolated buffer-perfused mouse lungs, basal vWF levels were significantly reduced in G?12(-/-), whereas thrombin-induced vWF secretion was defective in both EC-G?q(-/-);G?11(-/-) and G?12(-/-) mice. Using siRNA in cultured human umbilical vein ECs and human pulmonary artery ECs, depletion of G?12 and soluble N-ethylmaleimide-sensitive-fusion factor attachment protein ? (?-SNAP), but not G?13, inhibited both basal and thrombin-induced vWF secretion, whereas overexpression of activated G?12 promoted vWF secretion. In G?q, p115 RhoGEF, and RhoA-depleted human umbilical vein ECs, thrombin-induced vWF secretion was reduced by 40%, whereas basal secretion was unchanged. Finally, in vitro binding assays revealed that G?12 N-terminal residues 10-15 mediated the binding of G?12 to ?-SNAP, and an engineered ?-SNAP binding-domain minigene peptide blocked basal and evoked vWF secretion. Discovery of obligatory and complementary roles of G?12 and G?q/11 in basal vs evoked EC vWF secretion may provide promising new therapeutic strategies for treatment of thrombotic disease.
SUBMITTER: Rusu L
PROVIDER: S-EPMC3894496 | biostudies-literature | 2014 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA